Cissus Quadrangularis PCD Pharma Franchise Company
Cafoli Lifecare offers a Cissus Quadrangularis range of 3 formulations in softgel and tablet forms, manufactured in WHO-GMP certified facilities. Distributors building a bone-health and nutraceutical portfolio can secure district-wise monopoly franchise rights on this popular botanical.
What is Cissus Quadrangularis?
Cissus Quadrangularis, traditionally known as Hadjod, is a medicinal plant used in Ayurveda to support bone healing and joint health. It is marketed as a nutraceutical supplement, commonly combined with calcium and vitamin D3. Plant and constituent information is available on PubMed.
Applications
Cissus Quadrangularis supplements are used as adjuncts for fracture recovery support, bone density, joint comfort and general musculoskeletal wellness. They are recommended by orthopaedicians, physiotherapists and general physicians, and enjoy strong Ayurvedic and wellness OTC demand.
Why Cissus Quadrangularis is a High-Potential Molecule for Distributors
India's wellness and nutraceutical market is expanding rapidly, and traditional bone-support botanicals like Hadjod ride both the Ayurveda and ortho-nutrition trends. As a supplement it sidesteps the price competition of generic antibiotics, and it slots naturally alongside calcium and vitamin D3 lines to raise average order value for franchise partners.
Why Choose Cafoli Lifecare
Cafoli Lifecare is a WHO-GMP compliant, DCGI-approved PCD pharma company with 1000+ franchise partners across India. Partners receive district-wise monopoly rights, promotional inputs including visual aids, MR bags and product cards, and consistent stock availability backed by quality-tested manufacturing.
References
- PubMed: Cissus Quadrangularis and bone health
- PubChem: Cissus Quadrangularis constituents
Our formulations of Cissus Quadrangularis find application in many critical therapeutic areas. Its therapeutic spectrum includes, but is not limited to: